Tissue inhibitor of metalloproteinase 1 (TIMP-1) may be an autocrine growth factor in scleroderma fibroblasts

Journal of Investigative Dermatology

Volumn 108, Issue 3, 1997, Pages 281-284

  Kikuchi, Kanako ^a   Kadono, Takafumi ^b   Furue, Masutaka ^a   Tamaki, Kunihiko ^b  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

systemic sclerosis; transforming growth factor

Indexed keywords

TISSUE INHIBITOR OF METALLOPROTEINASE; TRANSFORMING GROWTH FACTOR BETA2;

ARTICLE; CELL CULTURE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; DOSE RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IN VITRO STUDY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCLERODERMA; SKIN FIBROBLAST;

EID: 0031042888     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1111/1523-1747.ep12286457     Document Type: Article

References (24)

1. American Rheumatism Association, Subcommittee for scleroderma criteria of American Rheumatism Association diagnostic and therapeutic criteria committee: Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 23:581-590, 1980
2. Arcari P, Martinelli T, Salvatore F: The complete sequence of a full length cDNA for human liver glyceraldehyde-3-phospliate dehydrogenase: evidence for multiple mRNA species. Nucleic Acids Res 23:9179-9189, 1984
3. Bou-Gharios G, Osman J, Black C, Olsen I: Excess matrix accumulation in scleroderma is caused partly by differential regulation of stromelysin and TIMP-1 synthesis. Clin Chim Acta 231:69-78, 1995
4. Cawston TE: Protein inhibitors of metallo-proteinases. In: Barrett AJ, Salveson G (eds.). Proteinase Inhibitors. Elsevier, Amsterdam, 1986, pp 589-610
5. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159, 1987
6. Chua CC, Chua BHL: Tumor necrosis factor-α induces mRNA for collagenase and TIMP in human skin fibroblasts. Connect Tissue Res 25: 161-170, 1990
7. Docherty AJ, Lyons A, Smith BJ, Wright EM, Stephens PE, Harris TJR: Sequence of human tissue inhibitor of metalloproteinases and its identity to erythroid-potentiating activity. Nature 318:66-69, 1985
8. Fleischmajer R, Perlish JS, Krieg T, Timpl R: Variability in collagen and fibronectin synthesis by scleroderma fibroblasts in primary culture. J Invest Dermatol 76:400-403, 1981
9. Gabrielli A, De Loreto C, Taborro R, Candela M, Ricciatti A, Nitti C, Danielli M, DeLustro F, Dasch J, Danielli G: Immunohistochemical localization of intracellular and extracellular associated TGF-β in the skin of the patients with systemic sclerosis(scleroderma) and primary Raynaud's phenomenon. Clin Immunol Immunopathol 68:340-349, 1993
10. Gruschwitz M, Muller P, Sepp N, Hofer E, Fontana A, Wick G: Transcription and expression of transforming growth factor type beta in the skin of progressive systemic sclerosis: a mediator of fibrosis? J Invest Dermatol 94:197-203, 1990
11. Hayakawa T, Yamashita K, Tanzawa K, Uchijima E, Iwata K: Growth-promoting activity of tissue inhibitor of metalloproteinases-l (TIMP-1 ) for a wide range of cells. FEBS Lett 298:29-32, 1992
12. Higley H, Persichitte K, Chu S, Waegell W, Vancheeswaran R, Black C: Immunocytochemical localization and serologic detection of transforming growth factor beta 1. Association with type 1 procollagen and inflammatory cell markers in diffuse and limited systemic sclerosis, morphea, and Raynaud's phenomenon. Arthritis Rheum 37:278-288, 1994
13. Kikuchi K, Kadono T, Ihn H, Sato S, Igarashi A, Nakagawa H, Tamaki K, Takehara K: The growth regulation of scleroderma fibroblasts: increased response to transforming growth factor β1. J Invest Dermatol 105:128-132, 1995a
14. Kikuchi K, Kubo M, Sato S, Fujimoto M, Tamaki K: Serum tissue inhibitor of metalloproteinases in patients with systemic sclerosis. J Am Acad Dermatol 33:973-978, 1995b
15. Kirk TZ, Mark ME, Chua CC, Chua BH, Mayes M: Myofibroblasts from scleroderma skin synthesize elevated levels of collagen and tissue inhibitor of metalloproteinase (TIMP-1) with two forms of TIMP-1. J Biol Chem 2711:3423-3428, 1995
16. LeRoy EC: Increased collagen synthesis by scleroderma fibroblasts in vito: a possible defect in the regulation or activation of the scleroderma fibroblast. J Clin Invest 54:880-889, 1974
17. LeRoy EC, Kahaleh MB, Mercurio S: A fibroblast mitogen present in scleroderma but not control sera. Inhibition by proteinase inhibitors. Rheumatol Int 3:35-38, 1983
18. Lotz M, Guerne P-A: Interleukin-6 induces the synthesis of tissue inhibitor of metalloproteinases-1/erythroid potentiating activity (TIMP-1/EPA). J Biol Chem 266:2017-2020, 1991
19. Murphy G, Reynolds JJ, Werb Z: Biosynthesis of tissue inhibitor of metalloproteinases by human fibroblasts in culture: stimulation by 12-o-tetradecanoyl-phorbol 13-acetate and interleukin 1 in parallel with collagenase. J Biol Chem 260:3079-3083, 1985
20. Overall CM, Wrata JL, Sodek J: Transcriptional and post-transcriptional regulation of 72kDa gelatinase/type IV collagenase by transforming growth factor-β1 in human fibroblasts. J Biol Chem 266:14064-14071, 1991
21. Potter SR, Bienenstock J, Lee P, Wilkinson S, Buchanan WW: Clinical association of fibroblast growth promoting factor in scleroderma. J Rheumatol 11:43-47, 1984
22. Takeda K, Hatamochi A, Ueki H, Nakata M, Oishi Y: Decreased collagenase expression in cultured systemic sclerosis fibroblasts. J Invest Dermatol 103:359-363, 1994
23. Uitto J, Bauer E, Eisen A: Scleroderma: increased biosynthesis of triple helical type I and type III procollagens associated with unaltered expression of collagenase in skin fibroblasts in culture. J Clin Invest 64:921-930, 1979
24. Unemori EN, Bouhana KS, Werb Z: Vectorial secretion of extracellular matrix proteins, matrix-degrading proteinases, and tissue inhibitor of metalloproteinases by endotbelial cells. J Biol Chem 265:445-451, 1990